Loong, H. H., Wong, C. K. H., Leung, L. K. S., Dhankhar, P., Insinga, R. P., Chandwani, S., . . . Tan, S. C. (2019). Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong. Pharmacoecon Open.
Chicago Style CitationLoong, Herbert H., et al. "Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy With Pembrolizumab As the First-Line Treatment for Metastatic NSCLC in Hong Kong." Pharmacoecon Open 2019.
MLA CitationLoong, Herbert H., et al. "Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy With Pembrolizumab As the First-Line Treatment for Metastatic NSCLC in Hong Kong." Pharmacoecon Open 2019.
Warning: These citations may not always be 100% accurate.